Although neurotrophic factors have been implicated in several forms of neuroplasticity, little is known concerning their potential role in spinal plasticity. Cervical dorsal rhizotomy (CDR) enhances serotonin terminal density near (spinal) phrenic motoneurons and serotonin-dependent long-term facilitation of phrenic motor output (Kinkead et al., 1998) . We tested the hypothesis that selected neurotrophic factors change in a manner consistent with an involvement in this model of spinal plasticity.
Although neurotrophic factors have been implicated in several forms of neuroplasticity, little is known concerning their potential role in spinal plasticity. Cervical dorsal rhizotomy (CDR) enhances serotonin terminal density near (spinal) phrenic motoneurons and serotonin-dependent long-term facilitation of phrenic motor output (Kinkead et al., 1998) . We tested the hypothesis that selected neurotrophic factors change in a manner consistent with an involvement in this model of spinal plasticity.
Brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), glial cell line-derived neurotrophic factor (GDNF), and transforming growth factor-␤ 1 (TGF-␤ 1 ) concentrations were measured (ELISA) in three regions of interest to respiratory control: (1) ventral cervical spinal segments associated with the phrenic motor nucleus (C3-C6), (2) ventral thoracic spinal segments associated with inspiratory intercostal motor output (T3-T6) and (3) the diaphragm. Tissues were harvested from rats 7 d after bilateral CDR and compared with sham-operated and unoperated control rats. CDR increased BDNF (110%; p ϭ 0.002) and NT-3 (100%; p ϭ 0.002) in the cervical and NT-3 in the thoracic spinal cord (98%; p ϭ 0.009). GDNF and TGF-␤ 1 were not altered by CDR in any tissue. Immunohistochemistry localized BDNF and NT-3 to motoneurons and interneurons of the ventral spinal cord. These studies provide novel, suggestive evidence that BDNF and NT-3, possibly through their trophic effects on serotonergic neurons and/or motoneurons, may underlie serotonin-dependent plasticity in (spinal) respiratory motor control after CDR.
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Spinal neuroplasticity has been widely appreciated only in recent years (Edgerton et al., 1992; Randic, 1996; Liou and Goshgarian, 1997; Neumann and Woolf, 1999) . Spinal plasticity has implications in the lifelong adjustments of important motor control systems (e.g., respiration and locomotion) and has potential to promote functional recovery after spinal cord injury. For example, cervical spinal hemisection enhances synaptic efficacy in existing, but functionally ineffective pathways that cross the spinal midline and innervate contralateral phrenic motoneurons (i.e., the "crossed phrenic phenomenon"; Goshgarian and Guth, 1977; Moreno et al., 1992) .
Spinal deafferentation also elicits plasticity in descending neurochemical pathways. For example, sensory denervation via dorsal rhizotomy augments descending serotonergic pathways from the raphe nuclei to the spinal dorsal horn (Zhang et al., 1993) . Cervical dorsal rhizotomy (CDR; C3-C5) eliminates sensory feedback from the diaphragm and elicits three forms of plasticity, including a slight enlargement of phrenic motoneurons (Zhan et al., 1997) , increased serotonergic terminal density in the immediate vicinity of phrenic motoneurons (Kinkead et al., 1998) , and an augmentation of serotonin-dependent long-term facilitation of respiratory (phrenic) motor output after episodic hypoxia (Kinkead et al., 1998) . Thus, CDR elicits both morphological and functional plasticity of pathways not associated with primary afferent neurotransmission. Dorsal rhizotomy may also elicit neurochemical (and presumably functional) plasticity in spinal regions distant from the site of denervation (Mitchell et al., 1995; Turner et al., 1997) .
Little is known concerning the cellular or molecular mechanisms that underlie spinal plasticity. Neurotrophic factors are implicated in short-and long-term enhancement of synaptic strength in the hippocampus (Kang and Shuman, 1995a,b; Sherwood and Lo, 1999) , the formation of ocular dominance columns in the visual cortex (Cabelli et al., 1995; Rossi et al., 1999) , and plasticity within the barrel cortex after whisker removal (Singh et al., 1997; Calia et al., 1998) . Neurotrophins and other neurotrophic factors, including members of the transforming growth factor-␤ superfamily, and their receptors are located in the spinal cord (Johnson et al., 1996; Yamamoto et al., 1996; DeLeo et al., 1997; Glazner et al., 1998; Dreyfus et al., 1999) and have potent neurotrophic effects on motoneurons (Elliott and Snider, 1996) and serotonergic neurons (Mamounas et al., 1995 (Mamounas et al., , 2000 .
To determine the potential of selected neurotrophic factors to play a role in spinal plasticity, four neurotrophic factors were studied in a model of selective spinal injury known to result in serotonin-mediated spinal plasticity (Kinkead et al., 1998) : cervical dorsal rhizotomy. Protein concentrations of two neurotrophins, brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), and two members of the transforming growth factor-␤ superfamily, glial cell line-derived neurotrophic factor (GDNF) and transforming growth factor-␤ 1 (TGF-␤ 1 ), were measured in adult rats after CDR.
MATERIALS AND METHODS
All procedures were approved by the University of Wisconsin Animal C are and Use Committee. Adult male rats (Harlan Sprague Dawley, Colony 236, Oregon, W I), ranging in mass from 248 to 334 gm (mean Ϯ SD, 284 Ϯ 18 gm) were divided into three groups: (1) bilateral CDR from C3 to C6 (n ϭ 6), (2) sham-operated (for BDN F, GDN F, and TGF-␤ 1 assays, n ϭ 2; for N T-3 assays, n ϭ 6), and (3) unoperated controls (n ϭ 6). For GDN F analysis, it was necessary to pool tissues from all four spinal segments from four rats to make one protein determination with the assay used in this study (ELISA). Thus, to achieve n ϭ 6, it was necessary to perform CDR on 24 rats.
Surg ical procedures. Bilateral CDR and sham operations were performed under isoflurane anesthesia after premedication with buprenorphine (0.3 mg / kg, i.p.). Dorsal laminectomy of cervical vertebrae 2-6 was completed, and the dura was cut. The dorsal rootlets were isolated from radicular vessels to the extent possible and were cut bilaterally from C3 to C6. Sham surgeries were performed in which the dorsal rootlets were isolated and identified but not transected. The muscles were apposed, and the skin was closed. No evidence of autotomy was observed after surgery in any rat. Rhizotomized and sham-operated rats were recovered for 7 d.
T issue preparation. Rats were killed with an overdose of pentobarbital and quickly immersed in liquid nitrogen for 8 sec. A ventral midline incision was made, and the diaphragm was removed and frozen (Ϫ80°C). The en bloc cervical (C3-C6) and thoracic (T3-T6) spinal cords were harvested based on the anatomical location of the ventral rootlets and rapidly placed on a freezing microtome (Ϫ32°C). The dorsal spinal cord was removed in successive 50 m sections until the ventral aspect of the central canal was seen. Tissues were stored at Ϫ80°C until neurotrophic protein concentrations were assessed.
Protein determination (ELISA). Following the protocols described by Okragly and Haak-Frendscho (1997) , tissue extracts were prepared. Tissue samples were weighed and homogenized in cold extraction buffer (Tris-buffered saline, pH 8.0, with 1% N P-40, 10% glycerol, 0.5 mM sodium metavanadate, 1 mM PMSF, 10 g /ml aprotinin, and 1 g /ml leupeptin). The homogenates were acidified to pH ϳ3.0 with 1N HC l, incubated at room temperature for 15 min, and neutralized with 1N NaOH to pH ϳ7.6. The pH was determined by measuring a drop of the homogenates on pH paper. After acid treatment, the homogenates were microf uged at 7000 ϫ g for 10 min, and the supernatants were assayed by sandwich ELISA.
Commercially available antibody sandwich ELISAs (Promega, Madison, W I) were used for the detection of BDN F (TB 257), N T-3 (TB 243), GDN F (TB 221), and TGF-␤ 1 (TB 196) in the tissue homogenate supernatants.
Statistical anal ysis. Reported values are expressed as picograms per gram of tissue wet weight. Statistical significance was assessed using a one-way ANOVA followed by a Student-Newman -Keuls post hoc test for multiple comparisons between treatment groups (SigmaStat; Jandel Scientific Software, San Rafael, CA). p Ͻ 0.05 was considered significant. Dixon's Q test (Rohrbacher, 1991) was used to detect outliers in the BDN F concentrations of thoracic spinal cords in control rats. On this basis, two data values were excluded from analysis.
To localize CDR-induced changes in BDN F and N T-3 within the ventral spinal cord, immunohistochemistry was performed. Rats were deeply anesthetized with sodium pentobarbital (75 mg / kg, i.p.) for transcardiac perf usion with 2% (BDN F) or 4% (N T-3) paraformaldehyde. Spinal cords were removed, post-fixed for 3 hr, and cryoprotected in 20% sucrose and 5% glycerin (4°C). Coronal sections (50 m) were cut on a freezing microtome and immediately processed for BDN F or N T-3 immunoreactivity following the antibody suppliers' recommendations with slight alterations as follows.
Free-floating sections processed for BDN F immunoreactivity were washed in Earl's buffered salt solution (EBSS) with 0.1% saponin (wash solution, pH 7.2-7.4) and incubated for 45 min in EBSS containing 0.1% saponin, 3 M sodium azide, and 1% hydrogen peroxide. Sections processed for N T-3 immunoreactivity were washed in 0.1 M PBS, pH 7.2-7.4, and incubated for 45 min in 0.3% hydrogen peroxide. Endogenous biotin was then blocked for 30 min with an avidin -biotin blocking kit (Vector Laboratories, Burlingame, CA). Staining was performed by incubating sections with primary anti-BDN F antibodies (5 g /ml for 12 hr at room temperature; R&D Systems, Minneapolis, M N) or anti-N T-3 antibodies (2 g /ml for 24 -48 hr at 4°C; R&D Systems), with secondary antibodies (BDN F, biotinylated goat anti-mouse; N T-3, biotinylated rabbit antigoat; Vector Laboratories) for 45 min, and with an avidin -biotinperoxidase reagent (1:500 dilution, ABC Elite; Vector Laboratories) for 30 min. Sections were then reacted with a solution containing 0.04% diaminobenzidine tetrahydrochloride, 0.01% hydrogen peroxide, and 0.14% nickel chloride in EBSS.
RESULTS
Comparisons of neurotrophic protein concentrations were made between three harvested tissues: (1) the ventral cervical spinal cord corresponding to the deafferented segments (C3-C6), (2) the diaphragm, because neurotrophic factors may be retrogradely transported to motoneurons (Curtis et al., 1998) , and (3) the ventral thoracic spinal cord from T3-T6, an area that provides motor innervation of the inspiratory intercostal muscles. Because the concentrations of neurotrophic factors were not significantly different between sham-operated and unoperated control rats in any tissue studied, with or without inclusion of statistical outliers, the data from these groups were pooled (data not shown). Thus, the stress of sham surgery and recovery was not sufficient to alter the expression of any protein studied. Differences in the concentrations of neurotrophic factors from rhizotomized versus control rats result specifically from chronic deafferentation of the cervical spinal segments.
CDR significantly increased BDNF levels in the ventral cervical cord versus the sham-operated and unoperated control group (110%, p ϭ 0.002; Fig. 1a ). In contrast, BDNF levels in the ventral thoracic spinal cord or diaphragm were unchanged by rhizotomy (Fig. 1a) . In the sham-operated and control rats, two measurements of BDNF concentration in the control thoracic spinal segments were excluded from analysis because they qualified as statistical outliers (Q ϭ 0.913). When the two outlying values were included in the data, the results of statistical analysis were similar: there were still no statistically significant differences in ventral thoracic BDNF concentration between CDR and shamoperated and control rats (1225 Ϯ 451 vs 526 Ϯ 55 pg/gm of tissue; p ϭ 0.21).
CDR significantly increased NT-3 concentration in the ventral cervical spinal cord (100%, p ϭ 0.002) when compared with control rats (Fig. 1b) . NT-3 was also increased significantly in the ventral thoracic spinal cord (98%, p ϭ 0.009), although not in the diaphragm (Fig. 1b) .
The concentrations of GDNF and TGF-␤1 were not altered by CDR in any tissue (Figs. 2a,b) . Figure 3 shows representative photomicrographs of the ventral spinal cord at C4 from two different CDR rats. Cross-sectional neuronal areas were crudely estimated from radial measurements of the cell body made with an eyepiece redicule and based on a spherical model. Strong BDNF immunostaining was seen in the ventral cervical spinal cord and was localized in a selective population of neurons, the majority being ϳ300 -900 m 2 in area (Fig. 3a, magnification, 400ϫ ). Labeling was seen within the soma and nuclei of cells, although little BDNF protein was observed in the white matter, glial cells, dendritic processes, or axons (Fig.  3a) . NT-3 was also localized in a selective population of neurons within the ventral cervical and thoracic spinal cords with approximately the same area as those labeled with BDNF (ϳ300 -900 m 2 ; Fig. 3b, magnification, 400ϫ) . However, NT-3 was also found within dendritic processes, as well as in axons within the white and gray matter. Some very small cells within the white matter (ϳ7-20 m 2 ), presumably glial cells, were also NT-3-immunoreactive (results not shown). Neither BDNF nor NT-3 immunoreactivity could be detected in terminals or varicosities, suggesting that neither protein was localized in descending fibers.
DISCUSSION
The results indicate that cervical spinal deafferentation increases BDNF and NT-3 protein concentrations within neurons of the ventral spinal cord. NT-3 changes occur in both the affected spinal segments (i.e., cervical), and in distant, functionally related regions of the spinal cord (i.e., rostral thoracic). Although a causal relationship has not been established, these data provide suggestive evidence that BDNF and NT-3 may play a role in spinal plasticity attendant to CDR: increased serotonin terminal density in the immediate vicinity of phrenic motoneurons and enhanced serotonin-dependent long-term facilitation of phrenic motor output after episodic hypoxia (Kinkead et al., 1998) . BDNF and NT-3 have many of the requisite characteristics to mediate such plasticity.
BDNF exerts reciprocal effects on serotonergic neurons within the CNS. For example, serotonin modulates BDNF mRNA in the CNS (Zetterström et al., 1999) , possibly via 5-HT 2A receptors (Vaidya et al., 1997 (Vaidya et al., , 1999 . In addition, exogenous BDNF reduces neurotoxin-induced loss of cortical 5-HT axons and promotes sprouting of 5-HT axons (Mamounas et al., 1995 (Mamounas et al., , 2000 . Thus, BDNF has the potential to play a role in the increased serotonergic innervation of the phrenic motor nucleus after CDR (Kinkead et al., 1998) .
Increased BDNF and NT-3 expression may represent a common response to a variety of spinal insults or changing conditions, acting to promote survival and/or increase the function of the affected motoneurons by initiating mechanisms of plasticity. For example, systemic administration of the glutamate agonist kainic acid results in experimentally induced seizures and dramatically increases spinal BDNF mRNA levels (Scarisbrick et al., 1999) . Similarly, BDNF mRNA is elevated in the lumbar spinal cord after 1-5 d of treadmill exercise, suggesting another model of activity-dependent increases in neurotrophin expression (Gómez-Pinilla et al., 1999) . Our results may also represent a form of activity-dependent neurotrophin expression. Diaphragmatic af- ferent neurons are primarily inhibitory to phrenic motor output (Speck and Revelette, 1987; Marlot et al., 1988) . Thus, CDR is expected to release the respiratory system from tonic or periodic inhibition, thereby enhancing activity in selected neural populations.
Increased NT-3 expression in ventral thoracic segments associated with inspiratory intercostal activity was somewhat surprising, although not without precedent. Thoracic dorsal rhizotomy from T3 to T12 in a caprine model augments serotonin concentration in cervical spinal segments associated with the phrenic motor nucleus in goats but not directly affected by the surgery (Mitchell et al., 1995; Turner et al., 1997) . Intercostal motoneurons providing motor output to (inspiratory) parasternal intercostal muscles are located primarily in rostral thoracic segments (DeTroyer et al., 1999) . Expiratory activity becomes more prevalent in the lower (caudal) thoracic segments (Larnicol et al., 1982; DeTroyer et al., 1999) . Although neurophysiological data from the intercostal muscles are not available, increased NT-3 in the ventral thoracic spinal cord may be associated with enhanced respiratory motor output to the inspiratory intercostal muscles, thereby preserving respiratory function after CDR. Collectively, these observations provide evidence that sensory deafferentation can elicit neurochemical plasticity in multiple, functionally related areas of the spinal cord. This finding raises the possibility that one form of functional compensation (apart from compensation at the site of injury or denervation) is to upregulate function in complementary neural structures that consequently assume a greater contribution to the task at hand, in this case breathing.
The distribution of BDNF and NT-3 immunolabeling in this study is consistent with previously published results (Kawamoto et al., 1998; Dreyfus et al., 1999) and indicates that the majority of BDNF and NT-3 in the ventral horn of the spinal cord is found within cell bodies, although it appeared to be located in both motoneurons and interneurons. However, the sources of BDNF and NT-3 protein are not entirely clear. Both BDNF and NT-3 can be anterogradely (Altar and DiStefano, 1998) and retrogradely (Curtis et al., 1998) transported in the CNS. Studies showing that BDNF and NT-3 mRNAs are expressed within spinal motoneurons (Scarisbrick et al., 1999) provide suggestive evidence that these neurotrophic factors may be produced within the motoneurons and/or interneurons per se. Because we saw little evidence for increased fiber or terminal labeling after CDR, it does not appear that the increased neurotrophin levels originated at distant, descending neural systems such as the raphe nuclei or locus coeruleus. Furthermore, the proteins do not appear to have been retrogradely transported from the diaphragm, because diaphragm concentrations were unaffected by CDR.
We chose to study responses of the ventral cervical spinal cord to deafferentation because this is an area that is critical to respiratory motor control. Although little is known concerning neurotrophic factors and respiratory motor control, BDNF is required for survival and the development of normal breathing behavior (Erickson et al., 1996; Balkowiec and Katz, 1998) . BDNF null mutants (bdnf Ϫ/Ϫ ) lack BDNF-dependent primary sensory neurons that link the carotid body and brainstem and, as a result, exhibit pronounced respiratory depression, resulting in death shortly after birth (Hertzberg et al., 1994; Erickson et al., 1996) . We speculate that spinal BDNF may also be important in the respiratory function of adult mammals. For example, BDNF might play a critical modulatory role in circumstances in which the respiratory control system has been compromised, allowing a degree of plasticity in the system that allows for a continual adjustment to changing physiological or environmental conditions. In summary, an upregulation of BDNF and NT-3 protein concentration within the ventral cervical spinal cord may exert trophic influences on phrenic motoneurons and/or serotonergic neurons that innervate the phrenic motor nucleus. Our studies provide novel, suggestive evidence that neurotrophins underlie serotonin-dependent plasticity in (spinal) respiratory motor control and, thereby, implicate BDNF and NT-3 more generally in Figure 3 . Photomicrographs of immunohistochemical reaction products for BDNF ( a) and in the C4 ventral horn from two CDR rats. BDNF was primarily localized within neurons of the ventral spinal cord. Size and location suggest that these neurons include both motoneurons and interneurons; however, only presumed motoneurons (based on neuronal area) are seen at this magnification (a, black arrow; magnification, 400ϫ). BDNF localized mainly to the cytoplasm and nuclei, with little staining observed in white matter, dendritic processes, nerve terminals, or nerve fibers. A similar pattern of localization was seen for NT-3 immunoreactivity; the majority of NT-3 protein was detected within neurons (b; magnification, 400ϫ). However, NT-3 was also observed within dendritic processes (white arrow), as well as in axons within the white and gray matter. Some very small cells within the white matter, presumably glial cells, were also labeled with the NT-3 antibody (results not shown).
